Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

InVivo sells off from recent run-up; shares down 26%

Published 06/23/2017, 03:35 PM
© Reuters.  InVivo sells off from recent run-up; shares down 26%
NVIVQ
-
  • Longs in InVivo Therapeutics (NVIV -26%) are getting cold water in the face today. Shares are down on more than triple normal volume after running up over 80% since last week. The degree of selling appears excessive so investors should be wary of an equity offering or other dilutive event.
  • On Tuesday, the company announced the 16th participant in the INSPIRE study assessing its Neuro-Spinal Scaffold in patients with complete thoracic AIS A spinal cord injury. Enrollment should be completed next quarter.
  • Now read: Modulating the tumor micro-environment


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.